Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Sanwa Kagaku licenses Bayer antidiabetic agent for Japanese development

July 20, 1998

No Comments

New treatment for male hypogonadism introduced in Germany

July 20, 1998

No Comments

Novel compounds described by Japan Energy for lipid disorders

July 20, 1998

No Comments

LY-117018 is fully protective during the later slow phase of bone loss

July 20, 1998

No Comments

Lilly describes several further series of estrogen receptor modulators

July 17, 1998

No Comments

Genzyme General and Pharming to collaborate on Pompe's disease treatment

July 17, 1998

No Comments

Genetronics develops TDD method for treating ED, seeks partners to carry on

July 16, 1998

No Comments

Amylin completes enrollment in U.S. for phase III pramlintide studies

July 16, 1998

No Comments

Vasomax NDA submitted for FDA review

July 16, 1998

No Comments

Lilly describes serotonergic agents for treating obesity, CNS disorders

July 15, 1998

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Endocrine/metabolic
RSS

Sanwa Kagaku licenses Bayer antidiabetic agent for Japanese development

New treatment for male hypogonadism introduced in Germany

Novel compounds described by Japan Energy for lipid disorders

LY-117018 is fully protective during the later slow phase of bone loss

Lilly describes several further series of estrogen receptor modulators

Genzyme General and Pharming to collaborate on Pompe's disease treatment

Genetronics develops TDD method for treating ED, seeks partners to carry on

Amylin completes enrollment in U.S. for phase III pramlintide studies

Vasomax NDA submitted for FDA review

Lilly describes serotonergic agents for treating obesity, CNS disorders

Today's news in brief

Today's news in brief

Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal

Proteomics study explores how protein changes influence disease

Abbvie and Simcere enter a $1B T-cell engager deal

Endocrine/metabolic RSS

Endocrine/metabolic
RSS